Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of human MAK assessed as residual activity at 30 uM relative to control
Assay data:1 Tested
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of MAK (unknown origin) at 1 uM by kinase-profiling analysis
MAK DiscoveRx kinase panel
SummaryRelated BioAssays by Target
MAK(h) Kinase panel
Inhibition of MAK (unknown origin) at 1 uM
KinomeScan assay: inhibition of MAK
Assay data:108 Tested
MAK(h) Eurofins kinase panel
MAK(h) Eurofins Kinase panel
MAK(h) Millipore kinase panel
Inhibition of wild-type human partial length MAK (M1 to P314 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control
Inhibition of human MAK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control
Inhibition of DNA-tagged human MAK assessed as percent of control at 50000 nM by qPCR analysis relative to control
Inhibition of human MAK assessed as percent of control at 1000 nM by KINOMEscan assay relative to control
Inhibition of MAK (unknown origin) assessed as enzyme activity at 1 uM preincubated for 20 mins followed by ATP addition and measured after 120 mins in presence of [33P-gamma] ATP by hotspot kinase assay relative to control
Inhibition of human MAK assessed as residual activity using MBP as substrate at 1 uM by [gamma-33P]-ATP assay relative to control
Inhibition of human MAK using MBP as substrate by [gamma-33P]-ATP assay
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Inhibition of human MAK using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control
Assay data:2 Tested
Inhibition of biotinylated ligand binding to wild-type human partial length MAK (M1 to P314 residues) expressed in bacterial expression system at 50 nM measured after 1 hr by kinomescan assay relative to control
Inhibition of wild-type human partial length MAK (M1 to P314 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on